InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,308.13
(
0.09%
)
US TECH 100
18,182.00
(
0.62%
)
Dow Jones
39,806.77
(
-0.49%
)
Brent Oil
83.09
(
-0.53%
)
Bitcoin
70,958.29
(
-0.69%
)
Post# of 692873
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (6) Keep Next 10 Report Keyboard Shortcuts
Replies (6) Next 10 Prev Next

HyGro

Send PM Follow Ignore
Followers 21
Posts 3554
Boards Moderated 0
Alias Born 12/18/2019

HyGro

Re: SkyLimit2022 post# 520015

Friday, 10/07/2022 6:01:43 PM

Friday, October 07, 2022 6:01:43 PM

Post# of 692873
But yet NWBO's Phase 3 trial ISN"T an adaptive trial. Post hoc trial design manipulation is not adaptive. It has to be designed and approved prior to trial initiation. NWBO's trial certainly wasn't. Just desperate manipulation post hoc.
Public Reply Private Reply New Post
Keep Last Read
Replies (6) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (6) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NWBO News
More NWBO News
InvestorsHub NewsWire

Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM

Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM

VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM

ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM

Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM

Avant Technologies to Revolutionize Data Center Management with Proprietary AI Software Platform • AVAI • May 16, 2024 8:00 AM

Start posting your company's news
Only $200 per official company press release!